BenzingaOctober 21, 2026 at 4:40 AM NY6 Days Ago
HeartBeam Completes Enrollment Ahead Of Schedule In 486-Patient HEADSTART-ACS Study
HEADSTART-ACS study conducted in collaboration with Indonesia’s National Cardiovascular Center in world’s fourth most populous country, representing strategically significant market of 288 million peopleData analysis is
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
